ZIOPHARM ONCOLOGY INC Insider Trading for January 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC for January 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | M | 0.08 | 242,979 | 19,438 | 0 | |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | M | 0.08 | 25,674 | 2,054 | 0 | |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | M | 0.08 | 242,979 | 19,438 | 778,406 | 535.4 K to 778.4 K (+45.38 %) |
| Jan 06 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Buy | M | 0.08 | 25,674 | 2,054 | 535,427 | 509.8 K to 535.4 K (+5.04 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Option Exercise | A | 4.34 | 25,000 | 108,500 | 25,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | WEISER MICHAEL | Director | Payment of Exercise | F | 4.34 | 5,854 | 25,406 | 171,032 | 176.9 K to 171 K (-3.31 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | MCINERNEY TIMOTHY | Director | Grant | A | 0.00 | 18,818 | 0 | 271,578 | 252.8 K to 271.6 K (+7.45 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Option Exercise | A | 4.34 | 300,000 | 1,302,000 | 300,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | LEWIS JONATHAN | CEO | Payment of Exercise | F | 4.34 | 15,023 | 65,200 | 509,753 | 524.8 K to 509.8 K (-2.86 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Option Exercise | A | 4.34 | 35,000 | 151,900 | 35,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | Vice Pres., Treasur ... | Payment of Exercise | F | 4.34 | 4,690 | 20,355 | 31,356 | 36 K to 31.4 K (-13.01 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Payment of Exercise | F | 0.00 | 2,339 | 0 | 106,525 | 108.9 K to 106.5 K (-2.15 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | Fowler Wyche | Director | Grant | A | 0.00 | 18,818 | 0 | 108,864 | 90 K to 108.9 K (+20.90 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 18,818 | 0 | 294,976 | 276.2 K to 295 K (+6.81 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | BRENNAN MURRAY | Director | Option Exercise | A | 4.34 | 25,000 | 108,500 | 25,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | EVP, CLO, and Secre ... | Option Exercise | A | 4.34 | 150,000 | 651,000 | 150,000 | |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | BELBEL CAESAR J | EVP, CLO, and Secre ... | Payment of Exercise | F | 4.34 | 7,193 | 31,218 | 45,594 | 52.8 K to 45.6 K (-13.63 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | KIRK RANDAL J | Director | Grant | A | 0.00 | 18,818 | 0 | 78,941 | 60.1 K to 78.9 K (+31.30 %) |